Literature DB >> 16825950

Involvement of oxidative stress in Alzheimer disease.

Akihiko Nunomura1, Rudy J Castellani, Xiongwei Zhu, Paula I Moreira, George Perry, Mark A Smith.   

Abstract

Genetic and lifestyle-related risk factors for Alzheimer disease (AD) are associated with an increase in oxidative stress, suggesting that oxidative stress is involved at an early stage of the pathologic cascade. Moreover, oxidative stress is mechanistically and chronologically associated with other key features of AD, namely, metabolic, mitochondrial, metal, and cell-cycle abnormalities. Contrary to the commonly held notion that pathologic hallmarks of AD signify etiology, several lines of evidence now indicate that aggregation of amyloid-beta and tau is a compensatory response to underlying oxidative stress. Therefore, removal of proteinaceous accumulations may treat the epiphenomenon rather than the disease and may actually enhance oxidative damage. Although some antioxidants have been shown to reduce the incidence of AD, the magnitude of the effect may be modified by individual factors such as genetic predisposition (e.g. apolipoprotein E genotype) and habitual behaviors. Because caloric restriction, exercise, and intellectual activity have been experimentally shown to promote neuronal survival through enhancement of endogenous antioxidant defenses, a combination of dietary regimen of low total calorie and rich antioxidant nutrients and maintaining physical and intellectual activities may ultimately prove to be one of the most efficacious strategies for AD prevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825950     DOI: 10.1097/01.jnen.0000228136.58062.bf

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  146 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Neuroprotective strategies involving ROS in Alzheimer disease.

Authors:  Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

Review 3.  Diet and neurocognition: review of evidence and methodological considerations.

Authors:  Patrick J Smith; James A Blumenthal
Journal:  Curr Aging Sci       Date:  2010-02

4.  Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients.

Authors:  Jose M Rubio-Perez; Maria D Albaladejo; Pilar Zafrilla; Maria L Vidal-Guevara; Juana M Morillas-Ruiz
Journal:  Eur J Nutr       Date:  2015-08-23       Impact factor: 5.614

Review 5.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 6.  Twenty years of metallo-neurobiology: where to now?

Authors:  Ashley I Bush; Cyril C Curtain
Journal:  Eur Biophys J       Date:  2007-11-10       Impact factor: 1.733

7.  Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: evidence for neuron-glia communication during energetic crisis.

Authors:  Samantha Zaroff; Paola Leone; Vladimir Markov; Jeremy S Francis
Journal:  Mol Cell Neurosci       Date:  2015-03-10       Impact factor: 4.314

Review 8.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 9.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

10.  Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease.

Authors:  Nofar Torika; Keren Asraf; Ella Roasso; Abraham Danon; Sigal Fleisher-Berkovich
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.